Trafalgar International (GCAN) Retained Earnings (2016 - 2026)
Trafalgar International (GCAN) posted Retained Earnings of -$5.0 million for Q1 2026, down 0.67% on a QoQ basis from -$5.0 million in Q4 2025, and down 2.5% year-over-year from -$5.2 million in Q1 2025.
Analysis
Trafalgar International (GCAN) Retained Earnings (2016 - 2026) Analysis & Trends
Trafalgar International has reported Retained Earnings for 11 years, with the latest figure at -$5.0 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 2.5% year-over-year to -$5.0 million in Q1 2026; TTM through Mar 2026 was -$5.0 million, a 2.5% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 7.12% from the prior year.
- Retained Earnings was -$5.0 million for Q1 2026 at Trafalgar International, down from -$5.0 million in the prior quarter.
- The five-year high for Retained Earnings was -$4.1 million in Q1 2022, with the low at -$5.3 million in Q3 2025.
- Average Retained Earnings over 5 years is -$4.6 million, with a median of -$4.5 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings decreased 18.91% in 2022, then slipped 2.5% in 2026.
- Over 5 years, Retained Earnings stood at -$4.3 million in 2022, then decreased by 4.39% to -$4.5 million in 2023, then slipped by 4.0% to -$4.7 million in 2024, then declined by 7.12% to -$5.0 million in 2025, then decreased by 0.67% to -$5.0 million in 2026.
- The last three Retained Earnings figures came in at -$5.0 million (Q1 2026), -$5.0 million (Q4 2025), and -$5.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -4.00 Bn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1.10 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 9.16 Bn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | -5.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -5.03 Mn |
| Dec 31, 2025 | -4.99 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Jun 30, 2025 | -5.29 Mn |
| Mar 31, 2025 | -4.90 Mn |
| Dec 31, 2024 | -4.66 Mn |
| Sep 30, 2024 | -4.62 Mn |
| Jun 30, 2024 | -4.57 Mn |
| Mar 31, 2024 | -4.53 Mn |
| Dec 31, 2023 | -4.48 Mn |
| Sep 30, 2023 | -4.43 Mn |
| Jun 30, 2023 | -4.38 Mn |
| Mar 31, 2023 | -4.34 Mn |
| Dec 31, 2022 | -4.29 Mn |
| Sep 30, 2022 | -4.25 Mn |
| Jun 30, 2022 | -4.14 Mn |
| Mar 31, 2022 | -4.08 Mn |
| Dec 31, 2021 | -3.93 Mn |
| Sep 30, 2021 | -3.74 Mn |
| Jun 30, 2021 | -3.48 Mn |